Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Single-carbon transferases are a class of enzymes responsible for transferring one-carbon groups (e.g., methyl, formyl, methylene) from a donor to an acceptor molecule in various cellular biochemical pathways[7][6]. This category includes key enzymes of one-carbon metabolism, particularly those dependent on the folate or methionine cycles, such as serine hydroxymethyltransferase (SHMT), methylenetetrahydrofolate reductase (MTHFR), dihydrofolate reductase (DHFR), and methionine synthase[1][2][4]. These enzymes are essential for the biosynthesis of nucleotides, amino acids, and methyl donors, and therefore play critical roles in DNA/RNA synthesis, protein production, redox balance, and epigenetic regulation through methylation reactions[1][2][3]. Disruption or dysregulation of single-carbon transferase activity is implicated in diseases such as cancer, cardiovascular, and neurodegenerative disorders, with these enzymes serving as established therapeutic targets—especially in antimetabolite cancer chemotherapy (e.g., antifolate drugs)[1][5]. The term "Single-carbon transfer enzymes" is not a canonical name for a single molecular target; it refers to a biochemical enzyme class, not a unique protein, receptor, or gene. Enzyme Commission (EC) number 2.1 is generally associated with these, particularly the methyltransferases[7]. For structured databases or drug targeting purposes, entries should typically be made for individual enzymes within this class (e.g., DHFR, SHMT), not the class as a whole. If a canonical target is needed, replace with a specific enzyme name such as "Serine hydroxymethyltransferase" or "Dihydrofolate reductase."
Inhibition of folate cycle enzymes (e.g., dihydrofolate reductase inhibition), Blockage of nucleotide synthesis, Blockage of methylation/demethylation reactions
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Single-carbon transferase.